← Open Payments lookup

DAVID STEINER: Open Payments

NPI 1972508802 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,739 in 78 payments from 15 companies in 2025. Trend: 2023 $1,394 · 2024 $1,508 · 2025 $1,739

Food & beverage: $1,640Education: $100
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$262
ABBVIE INC.7$197
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$195
Axsome Therapeutics, Inc.8$173
Otsuka America Pharmaceutical, Inc.8$161
Takeda Pharmaceuticals U.S.A., Inc.8$154
Neurocrine BioSciences, Inc.5$142
E.R. Squibb & Sons, L.L.C.6$138
Alkermes, Inc.4$82
Lundbeck LLC3$62

Products named: REXULTI, VRAYLAR, CAPLYTA, TRINTELLIX, INGREZZA, COBENFY, Auvelity, AUSTEDO XR.

Industry payments across SC — which companies pay providers there.